Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Gubra - Wrap up - H1-2023 interview med CEO Henrik Blou og CFO Kristian Borbos

By Claus ThestrupCEO, Sweden
Gubra

Gubra - Wrap up - H1-2023 interview med CEO Henrik Blou og CFO Kristian Borbos

Ledelsen i Gubra gav et meget konfident indtryk af væksten på deres første halvårs præsentation i går. Der er vækst indenfor samtlige områder i selskabet og inden offentliggørelsen af regnskabet var de ude med en opjustering til forventningerne for 2023 i deres service forretning CRO samt fastholdelse af forventningerne til deres D&P forretning.

Lyt til interviewet her: Gubra interview

Gubra deltager på HC Andersen Capital Life Science Seminar den 31. august kl. 9:30-9:55.

Disclaimer:

HC Andersen Capital modtager betaling fra Gubra for en Digital IR/Corporate Visibility abonnementsaftale. /Claus Thestrup  kl. 9:05 d. 29/8-2023

Login required

This content is only available for logged in users

Create account

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.